RxBenefits, Inc.

Breaking news! We are thrilled to announce the addition of Illuminate Rx to the RxBenefits marketplace of solutions – a new, innovative pharmacy benefits manager – designed by pharmacists, with a member-first philosophy and a focus on clarity, control, savings, and outcomes. Chief Pharmacy Officer Mark Campbell shares: “Pharmacy benefits management has been clouded by complexity and barriers to innovation for too long. With Illuminate Rx, we wanted to cut through the noise and give clients what they were asking for – unprecedented clarity, and optimized formulary, and network solutions.” Illuminate Rx doesn’t just claim transparency – it demonstrates it in practice. Intrigued? Learn how: https://rxbene.fit/47xRoKs #PharmacyBenefits #HealthcareInnovation #IlluminateRx

Rising prescription drug costs are straining employer healthcare budgets, driven by trends like surging GLP-1 utilization, direct-to-consumer advertising, and prescription overprescribing. These factors can lead to inefficiencies and misuse, making it difficult to control pharmacy spend. As our Chief Pharmacy Officer Mark Campbell explains in a recent article with Fierce Healthcare, strategic clinical management is essential to ensure the right patients get the right medications at the right time. https://rxbene.fit/3IoPEJm By implementing strategies like targeted medication reviews and human-led formulary oversight, employers can reduce unnecessary spending, ensure medications are used appropriately, and improve patient outcomes. #HealthcareInnovation #PharmacyManagement

When it comes to weight management solutions for employees, employers face a tough choice between two very different options – bariatric surgery and GLP-1 medications. Here's what we know so far: 𝗖𝗼𝘀𝘁 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲: • Bariatric surgery is a one-time, upfront expense. • GLP-1s, on the other hand, are a long-term, ongoing expense that can stretch over years. 𝗟𝗼𝗻𝗴-𝗧𝗲𝗿𝗺 𝗦𝘂𝗰𝗰𝗲𝘀𝘀: • Bariatric surgery has a wealth of data supporting its long-term impact on sustained weight loss and comorbidity reduction. • GLP-1s lack equivalent long-term data as they are relatively new to the market. 𝗟𝗶𝗳𝗲𝘀𝘁𝘆𝗹𝗲 𝗜𝗺𝗽𝗮𝗰𝘁𝘀: • Bariatric programs often require strict adherence to lifestyle changes like a healthy diet, exercise, and weight management strategies. • GLP-1s are typically used alone without mandatory monitoring or rigorous lifestyle interventions, although side effects of these drugs are not fully understood. 𝗛𝗲𝗮𝗹𝘁𝗵 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀: • Dramatic weight loss in the morbidly obese significantly reduces comorbidities such as type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and obstructive sleep apnea. 𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗿 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀: • For plans with high employee turnover, bariatric surgery may not yield a long-term return on investment. A short-term GLP-1 prescription could appear more cost-effective. • GLP-1 expenses can also be offset by rebates, copays, and adjusted cost-share strategies. While both solutions offer unique advantages, it’s clear there's no one-size-fits-all answer to address obesity as a chronic condition. Employers must weigh the financial and clinical impacts carefully before deciding which approach best aligns with their workforce's needs. What’s your take? Are you seeing higher interest in either bariatric surgery or GLP-1s within your benefits offerings? Share your thoughts in the comments! 👇 #HumanResources #BenefitsManagement #WorkplaceWellness

Rising drug prices have sparked a legislative frenzy, with nearly 1,500 pharmacy benefits-related bills introduced at the state level this year alone. What does this mean for plan sponsors and their pharmacy benefits cost concerns? In a new podcast from Fierce Healthcare, RxBenefits’ Senior Director and Managing Counsel Wesley Hill discusses the key focus areas of these bills and the challenges employers face in navigating the complicated maze created by a patchwork of state-level laws passed this year. This is a must-listen for healthcare executives and decision-makers looking for insights on the future of pharmacy benefits: https://rxbene.fit/42D8hjp #PharmacyBenefits #HealthcareLegislation

Pharmacy benefits plans can hide significant costs within the fine print. Choosing a transparent contract can mean the difference between saving money and surprise expenses. Consider asking these five questions about a pharmacy plan’s transparency in order to make informed choices: https://rxbene.fit/46duV4r For additional insights, listen to the latest episode of Pharmland on pharmacy benefits transparency: https://rxbene.fit/3JAyb0N #PharmacyBenefits #Healthcare

Introducing a bold, new – pharmacist designed – approach to pharmacy benefits. Illuminate Rx, the newest addition to our marketplace of PBM solutions, delivers unprecedented clarity and is designed to address the challenges posed by growing utilization of high-cost specialty medications and GLP-1s. Learn how: https://rxbene.fit/47xRoKs

How could the new 340B pilot rebate model impact hospitals and communities? In the latest episode of the ASHHRA Podcast, RxBenefits experts Sarah Hearn, MPH, Apexus Certified Expert™ and Sarah Jeanne McHale, Apexus Certified Expert™ join Rhiannon Klein to break down the big changes ahead. Learn how the shift to a rebate model could delay cash flow, increase administrative workload and jeopardize health care access - especially for at-risk rural hospitals. Tune in to the full episode here: https://rxbene.fit/4pff6S5 #HealthcareLeadership #340BProgram American Society for Healthcare Human Resources Administration (ASHHRA) The Bo and Luke Show ®️

Thank you to Logan Lutton for featuring CEO Robert Gamble in the recent Managed Healthcare Executive feature, which showcases how RxBenefits is changing the game in pharmacy benefits. Robert discusses our unique PBO approach – and spotlights the launch of Illuminate Rx, the new transparent PBM solution bringing more choice and clarity to plan sponsors. Check out the full interview: https://rxbene.fit/4mh94gU #HealthcareInnovation #PharmacyBenefits